Global Pricing & Access Lead, Rare Haematology
Core
Lead global market access, pricing, and reimbursement strategy for rare haematology medicines, specifically focusing on Paroxysmal Nocturnal Hemoglobinuria (PNH) and HSCT-TMA indications.
Role type
Director, Global Value Access and Pricing (GVAP)
Builds
Global value propositions, pricing frameworks, and market access toolkits for PNH and HSCT-TMA.
Domain
Rare diseases / Haematology / Pharmaceutical Market Access
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Global payer and HTA environment expertise, rare disease market access strategy, lifecycle management, evidence generation planning, cross-functional leadership, pricing strategy development, stakeholder negotiation
Preferred skills
Experience with EU payers or US commercial customers, knowledge of national/regional payer expectations
Technologies
None stated
Responsibilities
Lead cross-functional development of value propositions for PNH and HSCT-TMA; develop and implement global market access and pricing strategies; lead the monthly Haematology, Nephrology & Transplant payer working group; support local teams in P&R submissions and negotiations; monitor competitor market access and pricing developments; incorporate patient perspective into market access strategies.
Seniority
Director, strategic leadership
